Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIE While difficult-to-treat multidrug-resistant Gram-negative bacteria infections increase over time, the real-world effectiveness, use, and safety of ce…

4➡️Un article original évaluant l'utilisation et la sécurité de la ceftazidime-avibactam dans le traitement des patients hospitalisés pour une infection à bactéries Gram négatives multirésistantes.

www.sciencedirect.com/science/arti...

#IDSky #CeftazidimeAvibactam #ProspectiveStudy #Effectiveness

Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIE While difficult-to-treat multidrug-resistant Gram-negative bacteria infections increase over time, the real-world effectiveness, use, and safety of ce…

[Publication] The article "Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIE" is now available.

www.sciencedirect.com/science/arti...

#IDsky #CeftazidimeAvibactam #MultidrugResistantBacteria #GramNegativeBacteria #ProspectiveStudy

A 24-month National Cohort Study examining long-term effects of COVID-19 in children and young people - Communications Medicine Stephenson, Pinto Pereira et al. investigate the proportion of children and young people with Post Covid-19 condition 24-months post-infection. Only 7.2% meet the definition consistently at 3-, 6-, 12...

#LongCovid
#prospectivestudy

My abstract: Sequels found in 30% - and 7.2% for long covid symptoms - in large cohort of 11-17y.o. Britons with Sars-Cov-2 positive PCRs between Sept. 2020 and March 2021.
nature.com/articles/s43...

Context and implications: www.theguardian.com/world/2024/d...